A dose of Pfizer’s COVID-19 vaccine.Photo: Daniel Pockett/Getty
The Centers for Disease Control approved the Pfizer-BioNTech COVID-19 vaccine for emergency use in children 5 through 11 on Tuesday, the final step in its authorization.
The agency’s decision included input from independent advisory committee experts who unanimously agreed to making the vaccine available to this age group. The group met five days after an independent panel from the Food and Drug Administration “overwhelmingly voted in favor” of allowing the vaccine for use in kids 5 to 11, based onclinical trials showing that it was 90.7% effectivein preventing symptomatic illness.
Pfizer’s vaccine was authorized for children 12 through 15 years of age in May of this year. This decision now makes Pfizer’s the first vaccine in the country available to children under 12.
The statement from the FDA stipulated that the vaccine is almost 91 percent effective in kids 5 through 11, creating an immune response comparable to those 16 through 25.
The FDA also said that in an “ongoing study” looking at the safety of the vaccine in approximately 3,100 children, there have been no known side effects in the younger age bracket.
RELATED VIDEO: FDA Grants Full Approval to Pfizer’s COVID Vaccine
Never miss a story — sign up forPEOPLE’s free weekly newsletterto get the biggest news of the week delivered to your inbox every Friday.
The FDA said Friday that children 5 through 11 make up 39 percent of COVID-19 cases in individuals younger than 18 years of age, with roughly 8,300 kids being admitted to the hospital, according to the CDC.
Of those, 691 COVID-related deaths have been reported in the U.S. in children under 18, with 146 deaths reported in the 5 through 11 age group.
“I don’t really have any concern, as a physician and an immunologist” about the safety of the Pfizer vaccine in children," the White House’s chief medical advisor Dr. Anthony Faucitold CNNFriday. “I think it would be a good idea to vaccinate the children” when it becomes available.
The White House said that they have purchased enough vaccine doses to inoculate the 28 million kids between 5 and 11 years old in the U.S.
Though children are at a lower risk of severe disease and hospitalization from COVID-19, they can still get sick and pass the virus on to others.More children have been hospitalizedsince the emergence of the delta variant, and as of this month,children are testing positive for COVID-19at a disproportionately high rate. During the week of Oct. 14, those 18 and younger accounted for 25.5 percent of all cases in the U.S.,according to the American Academy of Pediatrics, despite making up just 22.2 percent of the total population.
Multiple large-scale studies have found that vaccines are safe.There is no scientific link between vaccines and autism, according to the Centers for Disease Control.
As information about thecoronavirus pandemicrapidly changes, PEOPLE is committed to providing the most recent data in our coverage. Some of the information in this story may have changed after publication. For the latest on COVID-19, readers are encouraged to use online resources from theCDC,WHOandlocal public health departments.PEOPLE has partnered with GoFundMeto raise money for the COVID-19 Relief Fund, a GoFundMe.org fundraiser to support everything from frontline responders to families in need, as well as organizations helping communities. For more information or to donate, clickhere.
source: people.com
